已收盘 12-12 16:00:00 美东时间
+0.100
+0.48%
CrossAmerica Partners (NYSE:CAPL) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.07 by 385.71 percent. This is a 25.93 percent increase over earnings of $0.27 per share
11-06 05:59
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
CrossAmerica Partners (NYSE:CAPL) declares $0.525/share quarterly dividend, in line with previous. Forward yield 10.03% Payable Nov. 13; for shareholders of record Nov. 3; ex-div Nov. 3. See CAPL Divi...
10-24 23:33
17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depressionNew post-hoc analysis of CAPLYTA®
10-10 19:33
证券之星消息,近日拓普集团(601689)新注册了5个项目的软件著作权,包括《定时器处理软件V1.0.0》、《一种基于NTC热敏电阻阻值变化查表计算温度的算法软件V1.0》、《汽车空气悬架ECU通信管理与安全校验软件V1.0》、《基于python脚本实现自动化生成故障管理软件模块代码的工具软件V1.0》、《基于CAPL和UDS协议实现的hex文件刷写工具V1.0》等。
08-31 01:46
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
CrossAmerica Partners (NYSE:CAPL) declares $0.525/share quarterly dividend, in line with previous. Forward yield 9.7% Payable Aug. 14; for shareholders of record Aug. 4; ex-div Aug. 4. See CAPL Divide...
07-24 22:37
CrossAmerica Partners LP (NYSE: CAPL) announced that it will release its second quarter 2025 earnings results on August 6, 2025. Management will host a conference call on August 7 at 9:00 a.m. ET. Participants can join via phone at 800-990-4333 or 646-769-9600 with passcode 280060. A live audio webcast will be available on the company's investor website, along with earnings materials. An archive of the webcast will be accessible within 24 hours f...
07-17 10:45
Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and only approved treatment for bipolar I and II depression as an adjunctive and monotherapy
07-08 20:02
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33